Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

11.13 USD -0.36 (-3.13%)
Streaming Delayed Price Updated: 10:44 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Optimism Building As Additional COVID-19 Vaccines Are Expected to be Released Globally
Financialnewsmedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Tcr2 Therapeutics, Inovio Pharmaceuticals, BioLineRx, Plug Power, or Arbutus Biopharma?
InvestorsObserver issues critical PriceWatch Alerts for TCRR, INO, BLRX, PLUG, and ABUS. 
From PR Newswire
INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA) and the Department of Defense's (DoD) Joi
- DARPA to fund innovative public-private partnership between INOVIO, The Wistar Institute, AstraZeneca, the University of Pennsylvania and Indiana University 
From PR Newswire
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
Dosing marks a key milestone for INO-4800 in China and its second Phase 2 clinical trial globally 
From PR Newswire
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
How Acute Respiratory Distress Syndrome (ARDS) May Be Affecting COVID-19 Patients
Financialnewsmedia.com News Commentary 
From PR Newswire
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18
DNA immunotherapy candidate VGX-3100 demonstrated resolution of HPV-16/18-associated precancerous anal lesions in 50% of treated patients six months after treatment 
From PR Newswire
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has... 
From PR Newswire
Thinking about buying stock in Sutro Biopharma, BioCryst Pharmaceuticals, Inovio Pharmaceuticals, Cocrystal Pharma, or Clean Energy Fuels?
InvestorsObserver issues critical PriceWatch Alerts for STRO, BCRX, INO, COCP, and CLNE. 
From PR Newswire
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.
Partnership with leading global plasmid manufacturer advances INOVIO's INO-4800 
From PR Newswire
InvestorNewsBreaks – A Glimpse into Robinhood’s 100 Most Popular Stocks
From InvestorBrandNetwork
Thinking about buying stock in AMC Entertainment, Inovio Pharmaceuticals, Sundial Growers, Nikola Corp, or Sorrento Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for AMC, INO, SNDL, NKLA, and SRNE. 
From PR Newswire
INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its DNA Medicine to Treat a Rare Disease Recurrent Respiratory Papillomatosis (RRP)
INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced it has... 
From PR Newswire
Thinking about trading options or stock in Pfizer, Inovio Pharmaceuticals, Alibaba, General Electric, or Nio?
InvestorsObserver issues critical PriceWatch Alerts for PFE, INO, BABA, GE, and NIO. 
From PR Newswire
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at
Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients 
From PR Newswire
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
FinancialNewsMedia.com News Commentary 
From PR Newswire
Thinking about buying stock in Pfizer, Moderna, Inovio Pharmaceuticals, AMC Entertainment, or HighPoint Resources?
InvestorsObserver issues critical PriceWatch Alerts for PFE, MRNA, INO, AMC, and HPR. 
From PR Newswire
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that it has... 
From PR Newswire
More Comprehensive Diagnostics are Needed as Cases Surge Once More
FinancialBuzz.com News Commentary 
From PR Newswire
Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Nanotechnology Based Approaches For Combating COVID-19 Could Fast-Track New Detection Modalities And Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
INOVIO Reports Third Quarter 2020 Financial Results
Investor Call Today at 4:30 PM ET 
From PR Newswire
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
Financialnewsmedia.com News Commentary 
From PR Newswire
Inhaled Nitric Oxide (INO) Market Precise Outlook 2020- Mallinckrodt Pharmaceuticals, Air Liquide S.A., Linde Plc (Praxair Inc.), Beyond Air Inc
Harrisburg, NC -- (SBWIRE) -- 10/29/2020 -- The Global Inhaled Nitric Oxide (iNO) Market Research Report 2020-2025 is a valuable source of insightful data for business strategists. It provides the... 
From SBWire - Latest Press Releases
INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020
INOVIO (NASDAQ: INO) announced today that third quarter 2020 financial results will be released after the market close on November 9, 2020. Following the release, the Company will host a live... 
From PR Newswire
Thinking about buying stock in Co-Diagnostics, Janus Henderson Group, Sorrento Therapeutics, Inovio Pharmaceuticals, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for CODX, JHG, SRNE, INO, and AAL. 
From PR Newswire
Thinking about buying stock in Sorrento Therapeutics, New Age Beverages, FuelCell Energy, Sunworks, or Inovio Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for SRNE, NBEV, FCEL, SUNW, and INO. 
From PR Newswire
Thinking about buying stock in Mobileiron Inc, Inovio Pharmaceuticals, Celldex Therapeutics, Snap Inc, or Aurora Cannabis?
InvestorsObserver issues critical PriceWatch Alerts for MOBL, INO, CLDX, SNAP, and ACB. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.